Khiron Life Sciences Corp KHRNF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.04
- Bid/Ask
- $0.01 / $0.01
- Market Cap
- $232.41
- Volume/Avg
- 7,300 / 22,302
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 310
- Website
- https://www.khiron.ca
Valuation
|
Metric
|
KHRNF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
KHRNF
|
|---|---|
Quick Ratio | 0.67 |
Current Ratio | 1.91 |
Interest Coverage | −62.71 |
Quick Ratio
KHRNF
Profitability
|
Metric
|
KHRNF
|
|---|---|
Return on Assets (Normalized) | −3.97% |
Return on Equity (Normalized) | −5.21% |
Return on Invested Capital (Normalized) | −3.59% |
Return on Assets
KHRNF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Ljyshqmkn | Lqrcp | $78.4 Bil | |
ZTS
| Zoetis Inc Class A | Bdrckqjtj | Txmh | $77.9 Bil | |
HLN
| Haleon PLC ADR | Brwtnkldk | Vmsnc | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Rmcnjbxyn | Dtgm | $18.8 Bil | |
VTRS
| Viatris Inc | Qqfzkmdvk | Pqj | $12.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Zgmfqpkt | Kblf | $12.0 Bil | |
CTLT
| Catalent Inc | Bgbdfycp | Glqnk | $9.7 Bil | |
PRGO
| Perrigo Co PLC | Bkcyygbt | Njzmc | $3.8 Bil | |
CURLF
| Curaleaf Holdings Inc | Nhxympvs | Kjs | $3.4 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bnrkqwtp | Flfnvdc | $3.2 Bil |